Steven J. Jungles

Steven J. Jungles

Former Senior Vice President and Chief Technical Operations Officer at Inozyme Pharma, Inc.

Are you Steven J. Jungles? Claim your profile
 

With ExecAtlas, you can:
  • IDENTIFY executive and board member connections in Steven J. Jungles's network.
  • FOLLOW changes in Steven J. Jungles's employment.
  • CONNECT with Steven J. Jungles through your network of contacts.

Steven J. Jungles's Executive Work History

Past
To view Steven J. Jungles's complete executive work history,
Age
58
 

Steven J. Jungles's Biography

Steven Jungles has served as our senior vice president and chief technical operations officer since May 2017. Mr. Jungles has also served as a consultant to SJJ BioConsulting LLC, a biopharmaceutical consulting company, since April 2015. Mr. Jungles served as senior vice president of technical operations at Ultragenyx Pharmaceutical Inc., a pharmaceutical company, from July 2011 to April 2015, and in various roles at BioMarin Pharmaceutical, Inc., a pharmaceutical company, from 1999 to July 2011. Mr. Jungles received a B.S. in biology from the University of Iowa.

Source: Inozyme Pharma, Inc. on 04/22/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Steven J. Jungles. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Steven J. Jungles's network.
  • FOLLOW changes in Steven J. Jungles's employment.
  • CONNECT with Steven J. Jungles through your network of contacts.
 

Access over 2,000,000 executive and board member profiles.

Example: Steven J. Jungles

Steven J. Jungles's Connections (21)

Dr. Joseph Schlessinger
Advisor, Celldex Therapeutics, Inc.
Axel Bolte
Board Member, Inozyme Pharma, Inc.
Lynne Marie Sullivan
Chief Financial Officer and Head, Corporate Development, Unity Biotechnology, Inc.
Catherine A. Nester
Vice President, Physician and Patient Strategies, Inozyme Pharma, Inc.
Martin W. Edwards M.D.
Board Member, Reata Pharmaceuticals, Inc.
Gus Khursigara Ph.D.
Vice President, Medical Affairs and Clinical Operations, Inozyme Pharma, Inc.
Stephen Basso
Chief Financial Officer, Innoviva, Inc.
Stephen J. DiPalma
Chief Financial Officer, Kernal Biologics
Sarah M. Bhagat Ph.D.
Board Member, Inozyme Pharma, Inc.
Kevin B. Johnson Ph.D.
Senior Vice President, Regulatory Affairs, Quality, and Product Development, Inozyme Pharma, Inc.
Equilar Homepage Equilar ExecAtlas Equilar BoardEdge Equilar Insight Research Services Knowledge Network About Us Login
© 2023 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993